Abstract
Objective: The aim of this study was to evaluate neoadjuvant chemotherapy (NACT) 3–4 cycles versus 6 or more courses followed by debulking surgery in advanced epithelial ovarian cancer (EOC), and compare it with primary surgery followed by NACT.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.